cemiplimab,fianlimab
regeneron,sanofi
['melanoma', 'fianlimab', 'thank you', 'cemiplimab', 'regeneron']
thank you for allowing me to discuss the data in relation to fianlimab (lag-3) + cemiplimab (pd1) in melanoma #asco23 log in and review ... 
Chief of Research and Immunotherapy  •  ImmunoOncology  •  Phase I  Clinical Trials  •  Melanoma  •  Cutaneous Oncology